It has been shown that PM treatment of A549 lung cancer cells resulted in the translocation of NF-κB into the nucleus, while IκB-α is phosphorylated, leading to the inactivation of the NF-κB-IκB-α complex. The gene discussed is NFKBIA; the disease is lung carcinoma.